• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

镰状细胞病患儿的高体重指数:一项单中心回顾性审计

High body mass index in children with sickle cell disease: a retrospective single-centre audit.

作者信息

Hall Rachael, Gardner Kate, Rees David C, Chakravorty Subarna

机构信息

Department of Haematology, Imperial College London, London, UK.

Department of Haematological Medicine, King's College London, London, UK.

出版信息

BMJ Paediatr Open. 2018 Oct 23;2(1):e000302. doi: 10.1136/bmjpo-2018-000302. eCollection 2018.

DOI:10.1136/bmjpo-2018-000302
PMID:30397666
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6202990/
Abstract

OBJECTIVE

To assess the prevalence of high body mass index (BMI) in children with sickle cell disease and assess correlation between BMI and disease severity.

DESIGN

Retrospective chart review followed by statistical analysis.

SETTING

A single tertiary paediatric clinic in inner city London.

PATIENTS

All patients with sickle cell disease, including homozygous haemoglobin (HbSS) and compound heterozygous Hb (HbSC), age 2-18 years receiving clinical care at the centre, were included in the study.

INTERVENTIONS

Height and weight measurements, steady-state laboratory blood tests, hospital admission rates, adjunct therapy such as hydroxycarbamide or blood transfusions and obstructive sleep apnoea (OSA) data were obtained from the hospital electronic patient records.

MAIN OUTCOME MEASURES

To study the prevalence of high BMI and to identify any correlation between BMI and disease severity.

RESULTS

385 patients were included. 64 children (17%) were overweight or obese, of which a significantly higher number of children with HbSC were obese or overweight (23 out of 91, 25%) compared with those with HbSS (36 out of 273, 13%), p≤0.001. No correlation was found between high BMI and presence of OSA, and markers of disease severity such as admission rates, fetal haemoglobin or lactate dehydrogenase levels.

CONCLUSIONS

High BMI did not correlate with disease severity in this cohort of patients with sickle cell disease. Obesity was more prevalent in females and those with HbSC. Further prospective studies are needed to determine long-term effects of BMI in disease severity and outcome.

摘要

目的

评估镰状细胞病患儿高体重指数(BMI)的患病率,并评估BMI与疾病严重程度之间的相关性。

设计

回顾性病历审查及后续统计分析。

地点

伦敦市中心的一家三级儿科诊所。

患者

纳入该研究的为所有年龄在2至18岁、在该中心接受临床护理的镰状细胞病患者,包括纯合血红蛋白(HbSS)和复合杂合血红蛋白(HbSC)患者。

干预措施

从医院电子病历中获取身高和体重测量值、稳态实验室血液检查结果、住院率、羟基脲或输血等辅助治疗以及阻塞性睡眠呼吸暂停(OSA)数据。

主要观察指标

研究高BMI的患病率,并确定BMI与疾病严重程度之间的相关性。

结果

共纳入385例患者。64名儿童(17%)超重或肥胖,其中HbSC患儿中超重或肥胖的人数显著多于HbSS患儿(91例中有23例,25%),而HbSS患儿中这一比例为273例中有36例,13%,p≤0.001。未发现高BMI与OSA的存在以及疾病严重程度指标(如住院率、胎儿血红蛋白或乳酸脱氢酶水平)之间存在相关性。

结论

在这组镰状细胞病患者中,高BMI与疾病严重程度无关。肥胖在女性和HbSC患者中更为普遍。需要进一步的前瞻性研究来确定BMI对疾病严重程度和预后的长期影响。

相似文献

1
High body mass index in children with sickle cell disease: a retrospective single-centre audit.镰状细胞病患儿的高体重指数:一项单中心回顾性审计
BMJ Paediatr Open. 2018 Oct 23;2(1):e000302. doi: 10.1136/bmjpo-2018-000302. eCollection 2018.
2
Characterising the prevalence of overweight and obese status among adults with sickle cell disease.描述镰状细胞病成年患者超重和肥胖状况的流行情况。
Br J Haematol. 2023 Mar;200(5):633-642. doi: 10.1111/bjh.18548. Epub 2022 Nov 16.
3
Endocrine and metabolic complications in children and adolescents with Sickle Cell Disease: an Italian cohort study.儿童和青少年镰状细胞病的内分泌和代谢并发症:一项意大利队列研究。
BMC Pediatr. 2019 Feb 11;19(1):56. doi: 10.1186/s12887-019-1423-9.
4
Association between hydroxycarbamide exposure and neurocognitive function in adolescents with sickle cell disease.羟基脲暴露与青少年镰状细胞病患者神经认知功能的关系。
Br J Haematol. 2020 Jun;189(6):1192-1203. doi: 10.1111/bjh.16519. Epub 2020 Feb 26.
5
6
Prevalence of raised body mass index in paediatric sickle cell disease.儿科镰状细胞病患者中体重指数升高的患病率。
J Paediatr Child Health. 2022 Oct;58(10):1829-1835. doi: 10.1111/jpc.16118. Epub 2022 Jul 13.
7
The effectiveness of web-based programs on the reduction of childhood obesity in school-aged children: A systematic review.基于网络的项目对学龄儿童肥胖症减轻的有效性:一项系统评价。
JBI Libr Syst Rev. 2012;10(42 Suppl):1-14. doi: 10.11124/jbisrir-2012-248.
8
Abnormality of erythrocyte membrane n-3 long chain polyunsaturated fatty acids in sickle cell haemoglobin C (HbSC) disease is not as remarkable as in sickle cell anaemia (HbSS).镰状细胞血红蛋白C(HbSC)病中红细胞膜n-3长链多不饱和脂肪酸的异常不如镰状细胞贫血(HbSS)明显。
Prostaglandins Leukot Essent Fatty Acids. 2006 Jan;74(1):1-6. doi: 10.1016/j.plefa.2005.10.002. Epub 2005 Nov 28.
9
The pattern of sickle cell disease in pregnancy in Lagos, Nigeria.尼日利亚拉各斯妊娠期镰状细胞病的模式。
West Afr J Med. 1993 Apr-Jun;12(2):96-100.
10
Kidney Disease among Patients with Sickle Cell Disease, Hemoglobin SS and SC.镰状细胞病、血红蛋白SS型和SC型患者中的肾脏疾病
Clin J Am Soc Nephrol. 2016 Feb 5;11(2):207-15. doi: 10.2215/CJN.03940415. Epub 2015 Dec 15.

引用本文的文献

1
Hemoglobin S Promotes Glycemic Dysregulation in a Mouse Model of Human Sickle Cell Disease.血红蛋白S在人类镰状细胞病小鼠模型中促进血糖失调。
Endocrinology. 2025 Apr 22;166(6). doi: 10.1210/endocr/bqaf082.
2
Characterising the prevalence of overweight and obese status among adults with sickle cell disease.描述镰状细胞病成年患者超重和肥胖状况的流行情况。
Br J Haematol. 2023 Mar;200(5):633-642. doi: 10.1111/bjh.18548. Epub 2022 Nov 16.
3
Adiponectin and Disease Severity in Sickle Cell Anemia Patients Attending a Tertiary Health Institution in Nnewi, Southeast Nigeria.尼日利亚东南部纽维一家三级医疗机构镰状细胞贫血患者的脂联素与疾病严重程度
Front Genet. 2022 Feb 23;13:799425. doi: 10.3389/fgene.2022.799425. eCollection 2022.
4
Letter to the Editor Concerning: Sharma, P.; McCarty, T. R.; Yadav, S.; Ngu, J. N.; and Njei, B. (2019). Impact of Bariatric Surgery on Outcomes of Patients with Sickle Cell Disease: a Nationwide Inpatient Sample Analysis, 2004-2014. Obesity Surgery, 1-8.致编辑的信 关于:夏尔马,P.;麦卡蒂,T. R.;亚达夫,S.;恩古,J. N.;以及恩杰伊,B.(2019年)。减重手术对镰状细胞病患者治疗结果的影响:2004 - 2014年全国住院患者样本分析。《肥胖外科》,第1 - 8页。
Obes Surg. 2019 Aug;29(8):2622-2623. doi: 10.1007/s11695-019-03953-x.
5
Response to Letter to the Editor: Impact of Bariatric Surgery on Outcomes of Patients with Sickle Cell Disease: a Nationwide Inpatient Sample Analysis, 2004-2014.致编辑的信的回复:减重手术对镰状细胞病患者治疗结果的影响:2004 - 2014年全国住院患者样本分析
Obes Surg. 2019 Aug;29(8):2624. doi: 10.1007/s11695-019-03956-8.

本文引用的文献

1
Sickle Cell Disease.镰状细胞病
N Engl J Med. 2017 Apr 20;376(16):1561-1573. doi: 10.1056/NEJMra1510865.
2
Body Mass Index and the Association With Vaso-occlusive Crises in Pediatric Sickle Cell Disease.体重指数与小儿镰状细胞病血管闭塞性危象的关联
J Pediatr Hematol Oncol. 2017 May;39(4):314-317. doi: 10.1097/MPH.0000000000000787.
3
Association between Body Mass Index, Waist-to-Height Ratio and Adiposity in Children: A Systematic Review and Meta-Analysis.儿童体重指数、腰高比与肥胖的关联:一项系统评价与Meta分析
Nutrients. 2016 Aug 20;8(8):512. doi: 10.3390/nu8080512.
4
Nutrient Insufficiencies/Deficiencies in Children With Sickle Cell Disease and Its Association With Increased Disease Severity.镰状细胞病患儿的营养不足/缺乏及其与疾病严重程度增加的关联。
Pediatr Blood Cancer. 2016 Jun;63(6):1060-4. doi: 10.1002/pbc.25940. Epub 2016 Feb 8.
5
BMI curves for preterm infants.早产儿 BMI 曲线。
Pediatrics. 2015 Mar;135(3):e572-81. doi: 10.1542/peds.2014-2777. Epub 2015 Feb 16.
6
Hydroxyurea and growth in young children with sickle cell disease.羟基脲治疗镰状细胞病幼年患者的生长情况。
Pediatrics. 2014 Sep;134(3):465-72. doi: 10.1542/peds.2014-0917.
7
From obesity genetics to the future of personalized obesity therapy.从肥胖遗传学到个性化肥胖治疗的未来。
Nat Rev Endocrinol. 2013 Jul;9(7):402-13. doi: 10.1038/nrendo.2013.57. Epub 2013 Mar 26.
8
Weight status of children with sickle cell disease.镰状细胞病患儿的体重状况。
Pediatrics. 2013 Apr;131(4):e1168-73. doi: 10.1542/peds.2012-2225. Epub 2013 Mar 4.
9
Population pharmacokinetics and pharmacodynamics of hydroxyurea in sickle cell anemia patients, a basis for optimizing the dosing regimen.羟基脲在镰状细胞贫血患者中的群体药代动力学和药效学,为优化给药方案提供了依据。
Orphanet J Rare Dis. 2011 May 28;6:30. doi: 10.1186/1750-1172-6-30.
10
Sickle-cell disease.镰状细胞病。
Lancet. 2010 Dec 11;376(9757):2018-31. doi: 10.1016/S0140-6736(10)61029-X. Epub 2010 Dec 3.